rss
Arch Dis Child Educ Pract Ed doi:10.1136/archdischild-2012-302876
  • Picket

Isoniazid prophylaxis started at 3–4 months of life does not prevent tuberculosis disease or infection in both HIV-infected and uninfected children

Setting: South Africa and Botswana

Patients: The study looked at infants who were born to HIV-infected women. To be included in the study, the infants had to be between 91 and 120 days of life, not infected with or exposed to a case of tuberculosis, without other chronic illness, or immunosuppressed from an infection other than HIV.

A total of 1351 children were included in the analysis and were split into two groups based on their HIV status after testing: HIV positive and HIV negative (table 1).

Intervention: The infants in both groups were randomly assigned to receive either isoniazid at a daily dose of 10–20 mg/kg or placebo. The study drug was initiated four days into randomisation, and continued for 96 weeks in total. All HIV-infected children continued to have access to …

Correspondence to Dr Mildred Adaku Iro, Department of Paediatrics, Queen Alexandra Hospital, Portsmouth PO6 3LY, UK; adakuiroh{at}yahoo.com

Register for free content

Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of ADC Education & Practice.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article